@FierceBiotech: Sanofi move to acquire more shares of Regeneron triggers market buzz. Report | Follow @FierceBiotech
@JohnCFierce: Tresiba news underscores how high the FDA sets the bar on diabetes. Hard for biotechs to play in a field like this. News | Follow @JohnCFierce
@RyanMFierce: 'Mercenary' coders crowd-sourced for immunology research software. Report | Follow @RyanMFierce
> Catabasis says that its Omega-3 therapy performed well in a slate of Phase I studies, demonstrating signs of efficacy against an inflammatory biomarker. Story
> With several of its late-stage development programs in trouble, analysts increasingly expect Merck's ($MRK) future to be closely tied to the fate of the sleep drug Suvorexant, now under regulatory review. Report
> A number of organizations in Scotland are getting involved with the 5-year European Lead Factory initiative. Story
Pharma News
@FiercePharma: Corks pop at Sanofi as FDA nixes Novo's Lantus challenger. Article | Follow @FiercePharma
@EricPFierce: New Celgene drug for multiple myeloma expected to help fuel expansion of market to $7.2 billion. News | Follow @EricPFierce
@AlisonBFierce: A genetically modified smallpox vaccine shrunk tumors in liver cancer patients and extended survival more than a year. More | Follow @AlisonBFierce
> FDA hearing on opioids reflects evolving view on painkiller use. Report
> Will NIH data win Avastin a new use in cervical cancer? Story
@FierceMedDev: Israeli team advances genetic device to perform DNA diagnosis. Report | Follow @FierceMedDev
@MarkHFierce: Indiana offers a way to work around the device tax, rather than focusing on repealing it. More | Follow @MarkHFierce
@DamianFierce: Pfizer's ongoing R&D slash and burn could be good news for CROs. Story | Follow @DamianFierce
> Japan's regulators push for quicker device approval process. News
> Indiana mulls industry tax break to counter federal device tax. Report
CRO News
> GSK ups the ante for trial transparency. Story
> Struggling Cardiome recruits Quintiles to handle heart drug. More
> Struggling Cardiome recruits Quintiles to handle heart drug. News
> QPS snags Florida trial site amid buying spree. Report
> Pfizer's Singapore slash and burn could be good news for CROs. Article
Biotech IT News
> Trials software outfit BioClinica reports annual results (for the last time?) Item
> Sanofi backs mobile service for cancer patients on chemo. News
> 'Mercenary' coders crowd-sourced for immunology research software. Report
> Biotech, pharma warming up to Facebook. Article
> Eli Lilly's virtual unit taps Oracle software for clinical trials. Story
And Finally… Investigators report that removing a protein called Gfi1 from leukemic cells made them particularly vulnerable to chemo and radiation in animal studies, offering a new approach to treating leukemia. Release